Autres langues Bioventus Inc.

Actions

BVS

US09075A1088

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 25/06/2024			Varia. 5j.	Varia. 1 janv.
5,48 ^USD	-1,97%		-5,84%	+3,98%

07/05	Bioventus Inc. révise ses prévisions de résultats pour l'année 2024	CI
07/05	Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024	07/05
Bioventus : Q1'24 Earnings Call Slides	07/05
Bioventus Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024	07/05
Earnings Flash (BVS) BIOVENTUS Reports Q1 Revenue $129.5M	07/05
Earnings Flash (BVS) BIOVENTUS Reports Q1 EPS $0.07	07/05
Bioventus Reports First Quarter Financial Results	07/05
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024	29/04
Bioventus : Q4’23 Earnings Call Slides	12/03
Earnings Flash (BVS) BIOVENTUS Posts Q4 Revenue $135.4M	12/03
Earnings Flash (BVS) BIOVENTUS Reports Q4 EPS $0.07	12/03
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results	12/03
Bioventus Inc. Provides Earnings Guidance for the Year 2024	12/03
Bioventus Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12/03
Bioventus Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	12/03
North American Morning Briefing : Inflation Data -2-	12/03
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024	04/03
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility	18/01
Bioventus Inc. Enters into an Amendment with Its Credit Agreement Lenders to Enhance Financial and Operational Flexibility	18/01
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole	12/01
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	27/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Bioventus Inc.

Actions

BVS

US09075A1088

Autres langues

Filtres